Health ❯ Medical Treatments

Pharmacology

GLP-1 Receptor Agonists Medications Weight Loss Medications Antibiotics Levodopa Ethics Sleep Disorders Complement Inhibitors Anticoagulants Antiplatelet Drugs Allergy Medications Dopamine Treatments Gene Therapy Antipsychotic Medications Drug Development Endocrine Disorders Antihypertensive Medications Botulinum Toxin Bone Health Medications Diabetes Medications Steroid Medications Corticosteroids Photopharmacology RNA-targeted Therapies Antifungal Medications

Eplontersen Fails to Cut Cardiovascular Deaths or Recurrent Events in Large ATTR-CM Trial

High baseline use of transthyretin stabilizers likely masked any incremental benefit and left prespecified subgroup signals favoring unstabilized or early-stage patients.

Experts Flag Nutrition Risks With GLP-1 Weight-Loss Drugs

AI Motion Analysis Uncovers Earliest Parkinson’s Sign in Mice